NUVB

1.66

0.00% 0.00

Handel nachbörslich: 1.60 -0.06 -3.61%

Nuvation Bio Inc (NUVB)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$1.66

Offen:

$1.69

24-Stunden-Volumen:

4.16M

Relative Volume:

1.65

Marktkapitalisierung:

$562.21M

Einnahmen:

Nettoeinkommen (Verlust:

$-75.80M

KGV:

-4.7429

EPS:

-0.35

Netto-Cashflow:

$-68.07M

1W Leistung:

-8.79%

1M Leistung:

-8.79%

6M Leistung:

-31.12%

1J Leistung:

-52.30%

1-Tages-Spanne:

$1.57

$1.69

1-Wochen-Bereich:

$1.57

$1.85

52-Wochen-Spanne:

$1.57

$3.97

Nuvation Bio Inc Stock (NUVB) Company Profile

Firmenname

Nuvation Bio Inc

Sektor

Healthcare (1162)

Branche

Biotechnology (673)

Telefon

(415) 754-3517

Adresse

357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO

Mitarbeiter

220

Twitter

Nächster Verdiensttermin

2025-03-05

Neueste SEC-Einreichungen

NUVB's Discussions on Twitter

Vergleichen Sie NUVB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NUVB Nuvation Bio Inc	1.66	562.21M	0	-75.80M	-68.07M	-0.35
VRTX Vertex Pharmaceuticals Inc	474.62	121.88B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	573.45	62.69B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	555.11	33.86B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	235.74	30.51B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	238.51	25.69B	3.81B	-644.79M	-669.77M	-6.24

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-27	Hochstufung	Jefferies	Hold → Buy
2024-03-26	Hochstufung	BTIG Research	Neutral → Buy
2023-01-06	Herabstufung	Jefferies	Buy → Hold
2022-08-02	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2022-08-02	Herabstufung	BTIG Research	Buy → Neutral
2022-05-04	Eingeleitet	H.C. Wainwright	Buy
2021-10-15	Fortgesetzt	BTIG Research	Buy
2021-04-06	Eingeleitet	RBC Capital Mkts	Outperform
2021-03-08	Eingeleitet	BMO Capital Markets	Outperform
2021-03-08	Eingeleitet	BTIG Research	Buy
2021-03-08	Eingeleitet	Cowen	Outperform
2021-03-08	Eingeleitet	Jefferies	Buy
2021-03-08	Eingeleitet	Wedbush	Outperform

Alle ansehen

Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten

Apr 03, 2025

Teacher Retirement System of Texas Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 03, 2025

Apr 02, 2025

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference - BioSpace

Apr 02, 2025

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB) - The Globe and Mail

Apr 02, 2025

Nuvation Bio Inc (NYSE: NUVB) – An Analysis Is What You Need - stocksregister.com

Apr 02, 2025

Apr 01, 2025

Nuvation Bio (NYSE:NUVB) Reaches New 52-Week LowHere's Why - MarketBeat

Apr 01, 2025

Quantbot Technologies LP Decreases Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 01, 2025

Mar 31, 2025

Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com

Mar 31, 2025

Mar 30, 2025

Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Mar 30, 2025

Mar 29, 2025

Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World

Mar 29, 2025

Mar 28, 2025

Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register

Mar 28, 2025

Mar 26, 2025

Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World

Mar 26, 2025

Mar 25, 2025

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - BioSpace

Mar 25, 2025

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 - BioSpace

Mar 25, 2025

Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib - Marketscreener.com

Mar 25, 2025

Insider Stock Buying Reaches US$720.1k On Nuvation Bio - Yahoo Finance

Mar 25, 2025

Breakthrough Lung Cancer Treatment Comparison: Taletrectinib Shows Head-to-Head Data vs Standard Therapy - Stock Titan

Mar 25, 2025

Mar 24, 2025

Bank of New York Mellon Corp Buys 14,203 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Mar 24, 2025

Mar 21, 2025

Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB) - Defense World

Mar 21, 2025

Mar 18, 2025

Nuvation Bio Inc (NYSE: NUVB) Is The Number One Stock Currently Moving. - Stocks Register

Mar 18, 2025

Mar 17, 2025

Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey

Mar 17, 2025

Arizona State Retirement System Grows Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Mar 17, 2025

Mar 15, 2025

10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey

Mar 15, 2025

Analysts Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $8.33 - Defense World

Mar 15, 2025

Mar 14, 2025

Jones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq

Mar 12, 2025

Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership - TipRanks

Mar 12, 2025

Jones Trading sets $10 target for Nuvation Bio stock with Buy rating - Investing.com Australia

Mar 12, 2025

Jones Trading sets $10 target for Nuvation Bio stock with Buy rating By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Nuvation Bio initiated with a Buy at JonesResearch - TipRanks

Mar 11, 2025

Nuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst Downgrade - Defense World

Mar 11, 2025

Nuvation Bio (NYSE:NUVB) Price Target Cut to $10.00 by Analysts at HC Wainwright - Defense World

Mar 11, 2025

Nuvation Bio stock price target cut to $10 by H.C. Wainwright - Investing.com Canada

Mar 11, 2025

Mar 10, 2025

Nuvation Bio (NYSE:NUVB) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat

Mar 10, 2025